Filing metadata

Accession number
0001209191-21-020250
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Mar 12, 2021
Reporting period
Mar 10, 2021
Description
Insider transaction

Explore SEC Filings Hub